OTC · ALDA
Atlantica, Inc.
$1.00$0.00 (0.0%)
Atlantica, Inc.’s quoted price sits in the upper half of its reported 52-week range, 9.09% below the high.
Loading market information…
OTC · VNTA · USD
Stock price
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Ventana Biotech, Inc.’s quoted price sits in the lower half of its reported 52-week range, 51.31% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Ventana Biotech, Inc. is an emerging biotechnology enterprise focused on the lifecycle of drug candidates for personalized medicine, encompassing the identification, assessment, acquisition, development, and eventual commercialization through partnerships of relevant intellectual property. The company's primary therapeutic area is addressing obesity and its associated medical conditions. Notably, Ventana holds proprietary rights to a medicated chewing gum formulation that integrates an extract of hoodia gordonii and 2-hydroxyoleic acid. This unique composition is intended for the management of obesity, hypertension, and various other metabolic disorders. Ventana is actively engaged in developing these appetite-suppressant chewing gums into distinct products: a lower-dosage version aimed at the over-the-counter market, and a higher-dosage variant slated for distribution via pharmacists. The lower-strength product is expected to be retailed in drugstores and health food establishments. Established in 1989, Ventana Biotech, Inc. operates from Butschwil, Switzerland. The company adopted its current name in October 2008, having previously been known as Personalica, Inc.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:09 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1.00$0.00 (0.0%)
Atlantica, Inc.’s quoted price sits in the upper half of its reported 52-week range, 9.09% below the high.
$0.00$0.00 (0.0%)
Manzo Pharmaceuticals, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.05$0.00 (0.0%)
Waverunner Capital Inc.’s quoted price sits in the lower half of its reported 52-week range, 67.76% below the high.
$0.00$0.00 (0.0%)
Hai Jia International Limited Company’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
All American Pet Company, Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.67% below the high.
$0.00+$0.00 (+12.5%)
Lotus Pharmaceuticals, Inc.’s quoted price sits in the upper half of its reported 52-week range, 34.68% below the high.
$0.00$0.00 (0.0%)
China Dongsheng International, Inc.’s quoted price sits in the lower half of its reported 52-week range, 77.98% below the high.
$0.00$0.00 (0.0%)
A1 Group, Inc.’s quoted price sits in the lower half of its reported 52-week range, 67.8% below the high.
